Gebelein et al., “The Release Of 5-Fluorouracil From Polycaprolactone Matrices,” Polym. Sci. Technol. 38(Appl. Bioact. Polym. Mater.):151-163, 1988. |
Golomb et al., Encyclopedic handbook of biomaterials and bioengineering, Part B: Applications, vol. 1 and 2, Wise et al. (eds.), Marcel Dekker, Inc., New York, NY, USA; Basel, Switzerland 1995, Chapter 37, “Perivascular Polymeric Controlled-Release Therapy,” pp. 1043-1055. |
Gonschior et al., “A new catheter for prolonged local drug application,” Coronary Artery Disease 6:329-334, 1995. |
Langer and Peppas, “Present and future applications of biomaterials in controlled drug delivery systems,” Biomaterials 2:201-214, 1981. |
Li and Feng, “Biodegradable polymeric matrix for long-acting and zero-order release drug delivery systems,” Makromol. Chem. Macromol. Symp. 33:253-264, 1990. |
Li et al., “Synthesis, characterization, and hydrolytic degredation of PLA/Peo?PLA triblock copolymers with long poly (L-lactic acid) blocks,” Macromolecules 29:57-62, 1996. |
Lovich and Edelman, “Mechanisms of Transmural Heparin Transport in the Rat Abdominal Aorta After Local Vascular Delivery,” Circulation Research 77(6):1143-1150, 1995. |
Lyatskaya and Birshtein, “Triblock copolymers: the role of interfacial tension coefficients at two interfaces,” Polymer 36(5):975-980, 1995. |
March et al., “Biodegradable Microspheres Containing a Colchicine Analogue Inhibit DNA Synthesis in Vascular Smooth Muscle Cells,” Circulation 89(5):1929-1933, 1994. |
Martini et al., “The bioadhesive properties of a triblock copolymer of ε-caprolactone and ethylene oxide,” International Journal of Pharmaceutics 113:223-229, 1995. |
Martini et al., “The Release of 5-Fluorouracil from a Swellable Matrix of a Triblock Copolymer of ε-Caprolacatone and Ethylene Oxide,” Pharmaceutical Research 12(11): 1786-1790, 1995. |
Matsuda et al., “Photoinduced prevention of tissue adhesion,” ASAIO Journal 38:M154-M157, 1992. |
Milas et al., “Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol,” Cancer Chemother. Pharmacol. 35:297-303, 1995. |
Miyamoto et al., “Polylactic Acid-Polyethylene Glycol Block Copolymer,” Clinical Orthopaedics and Related Research 294:333-343, 1993. |
Muller et al., “Intramural Methotrexate Therapy for the Prevention of Neointimal Thickening After Balloon Angioplasty,” JACC 20(2):460-466, 1996. |
Nakafuku and Sakoda, “Melting and crystallion of poly (L-lactic acid) and poly (ethylene oxide) binary mixture,” Polymer Journal 25(9):909-917, 1993. |
Nakayama and Matsuda, “Preparation and characteristics of photocrosslinkable hydrophillic polymer having cinnamate moiety,” Journal of Polymer Science: Part A: Polymer Chemistry 30:2451-2457, 1992. |
Nakayama and Matsuda, “Surface fixation of poly (ethylene glycol) via photodimerization of Cinnamate group,” Journal of Polymer Science: Part A: Polymer Chemistry 31:3299-3305, 1993. |
Nasser et al., “Microparticle depositon in periarterial microvasculature and intramural dissections after porous balloon delivery into atherosclerotic vessels: Quantitation and localization by confocal scanning laser microscopy,” American Heart Journal 131(5):892-898, 1996. |
Nojima et al., “Crystallization of Block Copolymers II. Morphological study of poly (ethylene glycol)-poly (ε-caprolactone) block copolymers,” Polymer Journal 24(11):1271-1280, 1992. |
Nojima et al., “Morphology formed in binary blends of poly (ε-caprolactone) and ε-caprolactone-butadiene diblock copolymer,” Polymer 36(14):2853-2856, 1995. |
Nomura et al., “Prediction of the Coding Sequences of Unidentified Human Genes. II. The Coding Sequences of 40 New Genes (KIAA0041-KIAA0080) Deduced by Analysis of cDNA Clones from Human Cell Line KG-1,” DNA Research 1:223-229, 1994. |
Okada et al., “Localized Release of Perivascular Heparin Inhibits Intimal Proliferation after Endothelial Injury without Systemic Anticoagulation,” Neurosurgery 25(6):892-898, 1989. |
Okana, “Molecular Design of Stimuli-Responsive Hydrogels for Temporal Controlled Drug Delivery,” Proceed. Intern. Symp. Control. Rel. Bioact. Mater 22:111-112, 1995. |
Okana et al., “Temperature-responsive poly (N-isopropylacrylamide) as a modulator for alteration of hydrophilic/hydrophobic surface properties to control activation/inactivation of platelets,” Journal of Controlled Release 36:125-133, 1995. |
Oliver et al., “Suppression of Collagen-Induced Arthritis Using and Angiogenesis Inhibitor, AGM-1470, and a Microtubule Stabilizer, Taxol,” Cellular Immunology 157:291-299, 1994. |
Osada and Ross-Murphy, “Intelligent Gels,” Scientific American (May):82-97, 1993. |
Oudhuis et al., “A comparison beween the morphology of semicrystalline polymer blends of poly(ε-caprolactone)/poly(vinyl methylether) and poly(ε-caprolactone)/(styrene-acrylonitrile),” Polymer 36(18):3936-3942, 1994. |
Paavola et al., “Controlled release of lidocaine from injectable gels and efficacy in rat sciatic nerve block,” Pharmaceutical Research 12(12):1997-2002, 1995. |
Palasis and Gehrke, “Permeability of responsive poly (N-isopropylacrylamide) gel to solutes,” Journal of Controlled Release 18:1-12, 1992. |
Park et al., “Poly (L-lactic acid)/pluornic blends: characterization of phase seperation behavior, degradation, and morphology and use as protein-releasing matrices,” Macromolecules 25:116-122, 1992. |
Peng et al., “Role of polymers in improving the results of stenting in coronary arteries,” Biomaterials 17:685-694, 1996. |
Peppas and Sahlin, “Hydrogels as mucoadhesive and bioadhesive materials: a review,” Biomaterials 17:1553-1561, 1996. |
Perego et al., “Preparation of a new nerve guide from a poly(L-lactide-co-6-caprolactone),” Biomaterials 15(3):189-193, 1994. |
Pitt, “Poly-ε-Caprolactone and Its Copolymers,” in Biodegradable Polymers as Drug Delivery Systems, (Eds. Langen, R., and Chasin, M), Marcel Dekker, New York, NY, pp 71-120, 1990. |
Pitt and Gu, “Modification of the rates of chain cleavage of poly(ε-caprolactone) and related plyseters in the solid state,” Journal of Controlled Release 4:283-292, 1987. |
Pitt et al., “Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (ε-caprolactone), and their copolymers in vivo,” Biomaterials 2:215-220, 1981. |
Pitt et al., “Biodegradable Drug Delivery Systems Based On Aliphatic Polyesters: Application To Contraceptives and Narcotic Antagonists,” in Richard W. Baker (ed.), Controlled Release Of Bioactive Materials [Symp. Int. Meet. Controlled Release Soc.], Academic Press, Inc., New York, NY, 1980, pp. 19-43. |
Pitt et al., “Blends of PVA and PGLA: control of the permeability and degradability of hydrogels by blending,” Journal of Controlled Release 19:189-200, 1992. |
Pitt et al., “Sustained Drug Delivery Systems II: Factors Affecting Release Rates from Poly(ε-caprolactone) and Related Biodegradable Polyesters,” Journal of Pharmaceutical Sciences 68(2):1534-1538, 1979. |
Pitt et al., “Sustained Drug Delivery Systems. I. The Permeability of Poly (ε-Caprolactone), Poly (DL-Lactic Acid), and Their Copolymers,” Journal of Biomedical Materials Research 13:497-507, 1979. |
Pitt et al., “The Enzymatic Surface Erosion of Aliphatic Polyesters,” Journal of Controlled Release 1:3-14, 1984. |
Ranucci and Ferruti, “High swelling gels for sensing applications,” Macromol. Symp. 109: 89-103, 1996. |
Rashkov et al., “Synthesis, characterization, and hydrolytic degradation of PLA/PEO/PLA triblock copolymers with short poly (L-lactic acid) chains,” Macromolecules 29:50-56, 1996. |
Rim and Runt, “Melting Behavior of Crystalline/Compatible Polymer Blends: Poly(ε-caprolactone)/Poly(styrene-co-acrylonitrile),” Macromolecules 16(5):763-768, 1983. |
Rowinsky and Donehower, “Paclitaxel (Taxol),” The New England Journal of Medicine 332(15):1004-1014, 1995. |
Rowinsky and Donehower, “Taxol: Twenty Years Later, the Story Unfolds,” Journal of the National Cancer Institute 83(24):1778-1781, 1991. |
Rowinsky et al., “Clinical Toxicities Encountered With Paclitaxel (Taxol®),” Seminars in Oncology 20(4 Suppl. 3):1-15, 1993. |
Rowinsky et al., “Taxol: A Novel Investigation Antimicrotubule Agent,” J. Natl. Cancer Inst. 82(15):1247-1259, 1990. |
Rowinsky et al., “Taxol: The First of the Taxanes, an Important New Class of Antitumor Agents,” Seminars in Oncology 19(6):646-662, 1992. |
Sauro et al., “The Anti-Tumor Agent, Taxol, Attenuates Contractile Activity In Rat Aortic Smooth Muscle,” Life Sciences 56(7):157-161, 1995. |
Sawhney and Hubbell, “Rapidly degraded terpolymers of dl-lactide, glycolide, and ε-caprolactone with increased hydrophilicity by copolymerization with polyethers,” Journal of Biomedical Materials Research 24:1397-1411, 1990. |
Shah et al., “A biodegradable injectable implant for delivering micro and macromolecules using poly(lactic-co-glycolic) acid (PLGA) copolymers,” Journal of Controlled Release 27: 139-147, 1993. |
Sharma and Straubinger, “Novel Taxol Formulations: Preparation and Characterization of Taxol-Containing Liposomes,” Pharmaceutical Research 11(6):889-896, 1994. |
Sharma et al., “Antitumor Effect of Taxol-containing Liposomes in a Taxol-resistant Murine Tumor Model,” Cancer Research 53:5877-5881, 1993. |
Sharma et al., “Antitumor Efficacy of Taxane Liposomes on a Human Ovarian Tumor Xenograft in Nude Athymic Mice,” Journal of Pharmaceutical Sciences 84(12):1400-1404, 1995. |
Sharma et al., “Novel Taxol® Formulation: Polyvinylpyrrolidone Nanoparticle-Encapsulated Taxol® for Drug Delivery in Cancer Therapy,” Oncology Research 8(7/8):281-286, 1996. |
Sharma et al., “Pharmaceutical and Physical Properties of Paclitaxel (Taxol) Complexes with Cyclodextrins,” Journal of Pharmaceutical Sciences 84(10):1223-1230, 1995. |
Shen-Guo and Bo, “Polycaprolactone-poly(ethylene glycol) block copolymer, I: Synthesis and Degradability in vitro,” Polymers for Advanced Technologies 4:363-366, 1993. |
Shen-Guo et al., “Polycaprolactone-poly (ethylene glycol) block copolymer, II. Relationship among composition, crystallinity and degradability,” Acta Polymeric Sinica 5:560-565, 1995 (+ English Abstract on p. 565). |
Shi et al., “Transcatheter Delivery of c-myc Antisense Oligomers Reduces Neointimal Formation in a Porcine Model of Coronary Artery Balloon Injury,” Circulation 90(2):944-951, 1994. |
Shively et al., “Physico-chemical characterization of polymeric injectable implant delivery system,” Journal of Controlled Release 33:237-243, 1995. |
Smetana Jr. et al., “Influence of intraperitoneal injection of three types of hydrogel beads on expression of carbohydrate-binding sites in spleen macrophages,” Biomaterials 17(24):2335-2341, 1996. |
Sollott et al., “Taxol Inhibits Neointimal Smooth Muscle Cell Accumulation after Angioplasty in the Rat,” J. Clin. Invest. 95:1869-1876, 1995. |
Spencer and Faulds, “Paclitex. A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Potential in the Treatment of Cancer,” Drugs 48(5):795-847, 1994. |
Tarr et al., “A New Parenteral Emulsion for the Administration of Taxol,” Pharmaceutical Research 4(2):162-165, 1987. |
Thomas et al., “Local intracoronary heparin delivery with a microporous balloon catheter,” Am. Heart J. 132(5):969-972, 1996. |
Trigo et al., “Anticancer drug, ara-C, release from pHEMA hydrogels,” Biomaterials 15(14): 1181-1186, 1994. |
Tsitsilianis et al., “Amphiphilic heteroarm star copolymers of polystyrene and poly (ethylene oxide),” Polymer 36(19):3745-3752, 1995. |
Tung, “Rheological behavior of poloxamer 407 aqueous solutions during sol-gel and dehydration processes,” International Journal of Pharmaceutics 107:85-90, 1994. |
Ulbrich et al., “Synthesis of novel hydrolytically degradable hydrogels for controlled drug release,” Journal of Controlled Release 34:155-165, 1995. |
Van den Mooter et al., “The Relation Between Sweeling Properties and Enzymatic Degradation of Azo Polymers Designed for Colon-Specific Drug Delivery,” Pharm. Res. 11(12):1737-1741, 1994. |
Violante and Lanzafame, “Cremaphor-free Paclitaxel Formulation,” Proceedings of the American Association for Cancer Research Annual Meeting vol. 36: Abstract No. 1841, 1995. |
Wada et al., “in Vitro Evaluation of Sustained Drug Release from Biodegradable Elastomer,” Pharmaceutical Research 8(10):1291-1295, 1991. |
Walter et al., “Interstitial Taxol Delivered from a Biodegradable Polymer Implant against Experimental Malignant Glioma,” Cancer Research 54:2207-2212, 1994. |
Wang et al., “Preparation and Characterization of Poly(lactic-co-glycolic acid) Microspheres for Targeted Delivery of a Novel Anticancer Agent, Taxol,” Chem. Pharm. Bull 44(10): 1935-1940, 1996. |
Wilensky et al., “Direct intraarterial wall injection of microparticles via a catheter: A potential drug delivery strategy following angioplasty,” Am. Heart J. 122(vol. 4)(Part 1):1136-1140, 1991. |
Wilensky et al., “Regional and arterial localization of radioactive microparticles after local delivery by unsupported or supported porous balloon catheters,” American Heart Journal 129(5):852-859, 1995 |
Winternitz et al., “Development of a Polymeric Surgical Paste Formulation for Taxol,” Pharmaceutical Research 13(3):368-375, 1996. |
Wolinsky et al., “Use of a Perforated Balloon Catheter to Deliver Concentrated Heparin Into the Wall of the Normal Canine Artery,” JACC 15(2):475-481, 1990. |
Woodward et al., “The intracellular degradation of poly(ε-caprolactone),” Journal of Biomedical Materials Research 19:437-444, 1985. |
Yang et al., “Structures of oxyethylene/oxybutylene diblock copolymers in their solid and liquid states,” Macromolecules 28:6029-6041, 1995. |
Yasurmori et al., “Placement of covered self-expanding metallic stents in the common bile duct: A feasibility study,” Journal of Vascular and Interventional Radiology Nov.-Dec.:773-778, 1993. |
Ye and Chien, “Dual-controlled drug delivery across biodegradable copolymer. II. Delivery kinetics of levonorgestrel and estradiol from (matrix/matrix) laminate drug delivery system,” Journal of Controlled Release 41:259-269, 1996. |
Yoshida et al., “Positive thermosensitive pulsatile drug release using negative thermosensitive hydrogels,” Journal of Controlled Release 32:97-102, 1994. |
Youxin and Kissel, “Synthesis and properties of biodegradable ABA triblock copolymers consisting of poly (L-lactic acid) or poly (L-lactic-co-glycolic acid) A-blocks attached to central poly (oxyethylene) B-blocks,” Journal of Controlled Release 27:247-257, 1993. |
Youxin et al., “In-vitro degradation and bovine serum albumin release of the ABA triblock copolymers consisting of poly (L(+)lactic acid), or poly(L(+)lactic acid-co-glycolic acid) A-blocks attached to central polyoxyethylene B-blocks,” Journal of Controlled Release 32:121-138, 1994. |
Yu and Grainger, “Novel thermo-sensitive amphiphilic gels: poly N-isopropylacrylamide-co-sodium acrylate-co-n-N-alkylacrylamide network synthesis and physicochemical characterization,” at Sixth International Symposium on Recent Advances in Drug Delivery Systems, Salt Lake City, Utah, USA, Feb. 21-24, 1993, pp. 820-821. |
Yu and Grainger, “Thermo-sensitive swelling behavior in crosslinked N-isopropylacrylamide networks: cationic, anionic and ampholytic hydrogels,” Polym. Prepr. 34(1):829-830, 1993. |
Zhou and Smid, “Physical hydrogels of associative star polymers,” Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem) 34(1): 822-823, 1993. |
Zhu et al., “Preparation, characterization, and properties of polylactide (PLA)-poly (ethylene glycol) (PEG) copolymers: a potential drug carrier,” Journal of Applied Polymer Science 39:1-9, 1990. |
Zhu et al., “Super microcapsules (SMC). I. Preparation and characterization of star polythylene oxide (PEO)-polyactide (PLA) copolymers,” Journal of Polymer Science: Part A: Polymer Chemistry 27:2151-2159, 1989. |
Harada et al., “Basic Fibroblast Growth Factor Improves Myocardial Function in Chronically Ischemic Porcine Hearts,” J. Clin. Invest. 94: 623-630, 1994. |
Riessen and Isner, “Prospects for Site-Specific Delivery of Pharmacologic and Molecular Therapies,” JACC 23(5): 1234-1244, 1994. |
Villa et al., “Local Delivery of Dexamethasone for Prevention of Neointimal Proliferation in a Rat Model of Balloon Angioplasty,” J. Clin. Invest. 93:1243-1249, 1994. |
Adams et al., “Taxol: A History of Pharmaceutical Development and Current Pharmaceutical Concerns,” Monogr. Natl. Cancer Inst. 15: 141-147, 1993. |
Ajani et al., “Activity of Taxol in Patients With Squamous Cell Carcinoma and Adenocarcinoma of th Esophagus,” J. Natl. Cancer Inst. 86: 1086-1091, 1994. |
Ali et al., “Mechanisms of polymer degradation in implantable devices,” Biomaterials 14(9): 648-656, 1993. |
Alkan-Onyuksel et al., “A Mixed Micellar Formulation Suitable for the Parenteral Administration of Taxol,” Pharmaceutical Research 11(2): 206-212, 1994. |
Anonymous, “Taxol,” The Lancet 339: 1447-1448, 1992. |
Anseth et al., “Mechanical properties of hydrogels and their experimental determination,” Biomaterials 17: 1647-1657, 1996. |
Bae et al., ““On-Off” thermocontrol of solute transport. I. Temperature dependence of swelling of N-isopropylacrylamide networks modified with hydrophobic components in water,” Pharmaceutical Research 8(4): 531-537, 1991. |
Bartoli et al., “In vitro and in vivo antitumoral activity of free, and encapsulated taxol,” J. Microencapsulation 7(2): 191-197, 1990. |
Belcheva et al., “Crosslinked poly (ethylene oxide) for drug release systems,” Macromol. Symp. 103: 193-211, 1996. |
Berrabah et al., “GC-MS determination of phenobarbitone entrapped in poly-ε-caprolactone nanocapsules,” Journal of Pharmaceutical & Biomedical Analysis 12(3): 373-378, 1994. |
Bissett and Kaye, “Taxol and Taxotere-Current Status and Future Prospects,” Eur. J. Cancer 29A(9): 1228-1231, 1993. |
Blanco-Fuente et al., “Tanned leather: a good model for determining hydrogels bioadhesion,” International Journal of Pharmaceutics 138: 103-112, 1996. |
Brahn et al., “Regression Of Collagen-Induced Arthritis With Taxol, A Microtubule Stabilizer,” Arthritis & Rheumatism 37(6): 839-845, 1994. |
Brem and Langer, “Polymer-Based Drug Delivery to the Brain,” Science and Medicine Jul./Aug.: 52-61, 1996. |
Bromberg, “Crosslinked poly (ethylene glycol) networks as reservoirs for protein delivery,” Journal of Applied Polymer Science 59: 459-466, 1996. |
Brown et al., in Comprehensive Polymer Science: The Synthesis, characterization, reactions and applications of polymers. vol 2-Polymer Properties, Allen et al (eds.)., Pergamon Press, Oxford, 1989, pp. 155-198. |
Bruin et al., “Biodegradable lysine diisocyanate-based poly(glycolide-co-ε-caprolactone)-urethane network in artificial skin,” Biomaterials 11: 291-295, 1990. |
Burt et al., “Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid),” Cancer Letters 88: 73-79, 1995. |
Calvo et al., “Study of the mechanisms of interaction of poly(ε-caprolactone) nanocapsules with the cornea by confocal laser scanning microscopy,” International Journal of Pharmaceutics 103: 283-291, 1994. |
Cascone et al., “Collagen and hyaluronic acid based polymeric blends as drug delivery systems for the release of physiological concentrations of growth hormone,” Journal of Materials Science Materials in Medicine 5: 770-774, 1994. |
Cerrai et al., “Block copolymers of L-lactide and poly (ethylene glycol) for biomedical applications,” Journal of Materials Science: Materials in Medicine 5: 308-313, 1994. |
Chen et al., “Novel hydrogels of a temperature-sensitive pluronic® grafted to a bioadhesive polyacrylic acid backbone for vaginal drug delivery,” Proceed. Intern. Symp. Control. Rel. Bioact. Mate. 22: 167-168, 1995. |
Coffin and McGinity, “17. Physical and Chemical Stability of Aqueous Colloidal Dispersions of Poly (DL-Lactide and Poly (ε-Prolactone),” Drug Targeting Delivery 1: 197-214, 1992. |
Cohn and Younes, “Compositional and structural analysis of PELA bioderadable block copolymers degrading under in vitro conditions,” Biomaterials 10: 466-474, 1989. |
Cornejo-Bravo et al., “Kinetics of drug release from hydrophobic polybasic gels: effect of buffer acidity,” Journal of Controlled Release 33: 223-229, 1995. |
Cserháti, “Interaction of some anticancer drugs with carboxymethyl-β-cyclodextrin,” International Journal of Pharmaceuticals 124: 205-211, 1995. |
De Scheerder et al., “Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries,” Athersclerosis 114: 105-114, 1995. |
Dinarvand and D'Emanuele, “The use of thermoresponsive hydrogels for on-off release of molecules,” Journal of Controlled Release 36: 221-227, 1995. |
Dolan et al., “Biodistribution of O6-benzyguanine and its effectiveness against human brain tumor xenografts when given in polythylene glycol or cremophor-EL,” Cancer Chemother Pharmacol 35: 121-126, 1994. |
Dong and Hoffman, “A novel approach for preparation of pH-sensitive hydrogels for enteric drug delivery,” Journal of Controlled Release 15: 141-152, 1991. |
Dong et al., “Controlled release of amylase from a thermal and pH-sensitive, macroporous hydrogels,” Journal of Controlled Release 19: 171-178, 1992. |
Dordunoo et al., “Release of taxol from poly(ε-caprolactone) pastes: effect of water-soluble additives,” Journal of Controlled Release 44: 87-94, 1997. |
Dordunoo et al., “Taxol encapsulation in poly(ε-caprolactone) microspheres,” Cancer Chemother Pharmacol 36: 279-282, 1995. |
Dunn et al., “Polystyrene-Poly (Ethylene Glycol) (PS-PEG2000) Particles as Model Systems for Site Specific Drug Delivery. 2. The Effect of PEG Surface Density on the in Vitro Cell Interaction and in Vivo Biodistribution,” Pharmaceutical Research 11(7): 1016-1022, 1994. |
Embelton and Tighe, “Polymers for Biodegradable medical devices. X. Microencapsulation studies: control of poly-hydroxybutyrate-hydroxyvalerate microcapsules porosity via polycaprolactone blending,” J. Microencapsulation 10(3): 341-352, 1993. |
Engelberg and Kohn, “Physico-mechanical properties of degradable polymers used in medical applications: a comparative study,” Biomaterials 12: 292-304, 1991. |
Ettinger, “Overview of Paclitaxel (TAXOL®) in Advanced Lung Cancer,” Seminars in Oncology 20(4 Suppl. 3): 46-49, Aug. 1993. |
Fernández-Ortiz et al., “A New Approach for Local Intravascular Drug Delivery (Iontophoretic Balloon),” Circulation 89(4): 1518-1522, 1994. |
French et al., “Physicochemical aspects of controlled release of substituted benzoic and napthoic acids from Carbopol® gels,” Journal of Controlled Release 37: 281-289, 1995. |
Fukuzaki et al., “A New Biodegradable Pasty-Type Copolymer of L-Lactic Acid and δ-Valerolactive With Relatively Low Molecular Weight for Application in Drug Delivery Systems,” Journal of Controlled Release 10: 293-303, 1989. |
Fukuzaki et al., “In vivo characteristics of low moleclar weight copolymers composed of L-Lactic acid and various DL-hydroxy acids as biodegradable carriers for drug delivery systems,” Biomaterials 11: 441-446, 1990. |
Gao et al., “Controlled Release of a Contraceptive Steroid from Biodegradable and Injectable Gel Formulations: In Vitro Evaluation,” Pharmaceutical Research 12(6): 857-863, 1995. |
Golomb et al., “Controlled delivery of a tryphostin inhibits hyperplasia in a rat cartoid artery injury model,” Atherosclerosis 125: 171-182, 1996. |
Gonschior et al., “Comparison of local intravascular drug-delivery catheter systems,” Am Heart J 130(6): 1174-1181, 1995. |
Grijpma et al., “Star-shaped polylactide-containing block copolymers,” Makromol. Chem. Rapid Commun. 14: 155-161, 1993. |
Grosvenor and Staniforth, “The effect of Molecular weight on the rheological and tensile properties of Poly(ε-caprolactone),” International Journal of Pharmaceutics 135: 103-109, 1996. |
Gu et al., “Biodegradable block copolymer matrices for long-acting contraceptives with constant release,” Journal of Controlled Release 22: 3-14, 1992. |
Gutowska et al., “Heparin release from the thermosensitive hydrogels,” Journal of Controlled Release 22: 95-104, 1992. |
Harland and Peppas, “Hydrophilic/hydrophobic, block and graft copolymeric hydrogels: synthesis, characterization, and solute partition and penetration” Journal of Controlled Release 26: 157-174, 1993. |
Harsh and Gehrke, “Controlling the swelling characteristics of temperature-sensitive cellulose ether hydrogels,” Journal of Controlled Release 17: 175-186, 1991. |
Hekmat, E., “Fatal Myocardial Infarction Potentially Induced By Paclitaxel,” Ann Pharmacother 30: 1110-1112, 1996. |
Heller et al., “The Sustained Release of Galardin and Taxol from Gelatin Chondroitin Sulfate Coacervate Films,” Mat. Res. Soc. Symp. Proc. 394: 55-60, 1995. |
Hoffman, “Applications of Thermally Reversible Polymers and Hydrogels in Therapeutics and Diagnostics,” at Third International Symposium on Recent Advances in Drug Delivery Systems, Salt Lake City, UT, Feb. 24-27, 1987, pp. 297-305. |
Hoffman, “Thermally Reversible Hydrogels Containing Biologically Active Species,” Polymers in Medicine III , C. Miglaires et al. (eds.), Elsevier Science Publishers B. V., Amsterdam, pp. 161-167, 1988. |
Hoffman et al., “Characterization pore Sizes and Water “Structure” in Stimuli-Responsive Hydrogels,” Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.) 34(1): 828, 1993. |
Holland et al., “Polymers for Biodegradable Medical Devices. 1. The Potential of Polyesters as Controlled Macromolecular Release Systems,” Journal of Controlled Release 4: 155-180, 1986. |
Hong et al., “The Effect of Porous Infusion Balloon-Delivered Angiopeptin on Myointimal Hyperplasia After Balloon Injury in the Rabbit,” Circulation 88(2): 638-648, 1993. |
Hu and Liu, “Effect of soft segment on degradation kinetics in polyethylene glycol/poly (L-lactide) block copolymers,” Polymer Bulletin 30: 669-676, 1993. |
Hu and Liu, “Effects of soft segments and hydrolysis on the crystallization behavior of degradable poly (oxyethylene)/poly (L-lactide) block copolymers,” Macromol. Chem. Phys.195: 1213-1223, 1994. |
Huehns et al., “Adventia as a target for intravascular local drug delivery,” Am Heart J 75: 537-538, 1996. |
Iwamiya et al ., “Repeated arterial infusion chemotherapy for inoperable hepatocellular carcinoma using an implantable drug delivery system.” Cancer Chemother Pharmacol. 33(Suppl.): S134-S138, 1994. |
Izuka et al., “Molecular weight dependence of viscoelasticity of polycaprolactone critical gels,” Macromolecules 25(9): 2422-2428, 1992. |
Jampel et al., “Glaucoma Filtration Surgery in Nonhuman Primates Using Taxol and Etoposide in Polyanhydride Carriers,” Investigative Ophthalmology & Visual Science 34(11): 3076-3083, 1993. |
Janarthanan et al., “Intramolecular Interactions in Poly(styrene-co-acrylonitrile)/Poly(ε-caprolactone) Blends,” Journal of Polymer Science:Part B:Polymer Physics 31: 1013-1017, 1993. |
Jedlinski et al., “Polymerization of lactones, 17 synthesis of ethylene glycol-L-lactide block copolymers,” Makromol. Chem. 194(6): 1681-1689, 1993. |
Jianzhong et al., “Polycaprolactone-poly (ethylene glycol) block copolymer, III. Drug release behavior,” Chinese Journal of Polymer Science 13(2): 154-161, 1995. |
Jin et al., “Lipobeads: a hydrogel anchored lipid vesicle system,” FEBS Letters 397: 70-74, 1996. |
Johnston et al., “Sustained Delivery of Interleukin-2 from a poloxamer 407 Gel Matrix Following Intraperitoneal Injection in Mice,” Pharmaceutical Research 9(3): 425-433, 1992. |
Jones et al., “Phase II Study of Paclitaxel Therapy for Unrespectable Biliary Tree Carcinomas,” Journal of Clinical Oncology 14(8): 2306-2310, 1996. |
Katono et al., “Thermo-responsive swelling and drug release switching of interpenetrating polymer networks composed of poly (acrylamide-co-butyl methacrylate) and poly (acrylic acid),” Journal of Controlled Release 16: 215-228, 1991. |
Kazanskii et al., Ionizable hydrogels of new type based on poly (ethylene glycol) phosphates, Polymer Gels and Networks 4: 335-349, 1996. |
Kelsen et al., “A Phase II Trial of Paclitaxel (Taxol) in Advanced Esophageal Cancer: Preliminary Report,” Seminars in Oncology 21(5): 44-48, 1994. |
Kennedy et al., “Prevention of experimental postoperative peritoneal adhesions by N,O-carboxymethyl chitosan,” Surgery 120(5): 866-870, 1996. |
Kim et al., “Hydrogels: swelling, drug loading, and release,” Pharmaceutical Reasearch 9(3): 283-290, 1992. |
Kimura et al., “Preparation of block copoly (ester-ether) comprising poly (L-lactide) and poly (oxypropylene) and degradation of its fibre in vitro and in vivo,” Polymer 30(7): 1342-1349, 1989. |
Koenig and Huang, “Biodegradable blends and composites of polycaprolactone and starch derivatives,” Polymer 36(9): 1877-1882, 1995. |
Kohler and Goldspiel, “Paclitaxel (Taxol),” Pharmacotherapy 14(1): 3-34, 1994. |
Kono et al., “Temperature-sensitive liposomes: liposomes bearing poly (N-isopropylacrylamide),” Journal of Controlled Release 30: 69-75, 1994. |
Krüger et al., “Elastic properties of thin ultraoriented poly (ε-caprolactone) films grown on PTFE substrates as revealed by brillouin spectroscopy,” Journal of Polymer Science: Part B: Polymer Physics 30: 1173-1176, 1992. |
Kumar and Himmelstein, “Modification of in Situ Gelling Behavior of Carbopol Solutions by Hydroxypropyl Methylcellulose,” Journal of Pharmaceutical Sciences 84(3): 344-348, 1995. |